Mark A. Feitelson

8.8k citations
144 papers · 7.9k · 3 hit papers · h-index 43

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver physiology and pathology
    • Hepatitis C virus research
  • Epidemiology top 0.5%
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis B Virus Studies 100
    • Hepatitis C virus research 16
    • Hepatocellular Carcinoma Treatment and Prognosis 12
    • Liver physiology and pathology 9

Mark A. Feitelson

143 papers receiving 7.6k citations

Mark A. Feitelson's Hit Papers

Sustained proliferation in cancer: Mechanisms and novel therapeutic targets 2015 · 615 citations
6150+4+8Years since publication200400600

Peers

Mark A. Feitelson
Comparison fields: 5 of 125
  • Hepatology 1.5k
  • Epidemiology 3.5k
  • Cancer Research 839
  • Oncology 1.2k
  • Molecular Biology 1.6k
Replace Ratna B. Ray with:
Ratna B. Ray United States
Carmen Berasain Spain
Jing‐hsiung James Ou United States
Robert Steele United States
Ulrich M. Lauer Germany
Leonard E. Post United States
Guann‐Yi Yu Taiwan
Keigo Machida United States
Le‐Xing Yu China
Massimo N. Pignatelli United Kingdom
Mark A. Feitelson relative to Ratna B. Ray United States Ratna B. Ray's profile →
Citations per field
00.5×2×2.5×
Ratna B. Ray · 1×
Citations per year

Countries citing papers authored by Mark A. Feitelson

Since Specialization
Citations

This map shows the geographic impact of Mark A. Feitelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Feitelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Feitelson more than expected).

Fields of papers citing papers by Mark A. Feitelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Feitelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Feitelson. The network helps show where Mark A. Feitelson may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Feitelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Feitelson Line = papers co-authored together Mark A. Feitelson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Hit paper breakdown →
2013692
2
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Hit paper breakdown →
2015615
3 1994587
4
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Hit paper breakdown →
2014515
5 1995323
6 2002280
7
Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma.
1993275
8 2015263
9 1990214
10
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.
1997206
11 2006198
12 2013124
13
Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
1991113
14 2013105
15 2011101
16 2011101
17 1991100
18 200598
19 202398
20 199991

About Mark A. Feitelson

Mark A. Feitelson is a scholar working on Epidemiology, Hepatology, Cancer Research, Oncology and Molecular Biology, having authored 144 papers that have together received 7.9k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (100 papers), Hepatitis C virus research (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver physiology and pathology (9 papers), Cancer-related Molecular Pathways (8 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Carcinogens and Genotoxicity Assessment (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Hepatology (1.5k citations), Epidemiology (3.5k citations), Cancer Research (839 citations), Oncology (1.2k citations) and Molecular Biology (1.6k citations). Mark A. Feitelson has collaborated with scholars based in United States, China and South Africa. Frequent co-authors include Alla L. Arzumanyan, Helena M. G. P. V. Reis, Karl Münger, Enrique A. Mesri, Zhaorui Lian, Jingbo Pan, Marcia M. Clayton, Bill S. Sun, Lingxun Duan and Curtis C. Harris. Their work appears in journals such as Hepatology, Journal of Virology, Oncogene, Journal of Hepatology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact